camptothecin has been researched along with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darzynkiewicz, Z; Li, X | 1 |
| Du, L; Lin, Z; Liu, JY; Lu, ZY; Luo, CM; Wen, LF; Yang, DC | 1 |
2 other study(ies) available for camptothecin and 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
| Article | Year |
|---|---|
Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation.
Topics: Apoptosis; Biomarkers; Boron Compounds; Camptothecin; Cell Cycle; Cell Division; Deoxyuracil Nucleotides; DNA Damage; Fluorescein-5-isothiocyanate; Fluorescent Dyes; HL-60 Cells; Humans; Sensitivity and Specificity; Topoisomerase I Inhibitors | 1995 |
A Hypoxia-Activated Prodrug Conjugated with a BODIPY-Based Photothermal Agent for Imaging-Guided Chemo-Photothermal Combination Therapy.
Topics: Azo Compounds; Boron; Boron Compounds; Camptothecin; Cell Line, Tumor; Humans; Hyperthermia, Induced; Hypoxia; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy; Porphobilinogen; Prodrugs | 2022 |